000			01531nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aNASH and Systemic Complications _bFrom Basic to Clinical Research
546			_aEnglish[eng]
650			_aNAFLD||mouse models||multifactorial disease||translational value||non-alcoholic fatty liver disease||steatohepatitis||NASH||cognitive impairment||memory dysfunction||Alzheimer’s disease||neurodegeneration||liver stiffness||liver steatosis||controlled attenuation parameter||transient elastography||MRI PDFF||MR spectroscopy||non-alcoholic steatohepatitis (NASH)||tunneling nanotubes (TNTs)||primary hepatocytes||organelle transfer||mesenchymal stromal cells||aminopyrine||microsomal||liver function||breath test||nonalcoholic fatty liver disease||nonalcoholic steatohepatitis||extracellular vesicles||magnesium (Mg2+)||obesity||insulin resistance (IR)||type 2 diabetes mellitus (T2DM)||hypertension||cardiovascular diseases (CVD)||non-alcoholic steatohepatitis||intestinal permeability||microbiota||probiotics||physical exercise||fecal microbiota transplantation||hepatocellular carcinoma||pathogenesis||extra-hepatic outcome||organ-on-a-chip||artificial intelligence||liver disease||GLP-1 agonist||SGLT-2 inhibitor||type 2 diabetes||innate immune system||adaptive immune system||metabolic syndrome||fatty liver||leptin||n/a
700			_aShiri-Sverdlov, Ronit||Baumgartner, Sabine
856			_uhttps://mdpi.com/books/pdfview/book/4913
942			_cEB
999			_c12878 _d12878